Clinical trialNCT02050048TerminatedPhase 2/PHASE3Interventional

High Volume Lactated Ringer's Solution and Pancreatitis

SponsorEndeavor HealthEnrollment26Pancreatitis

View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The purpose of this study is to examine whether giving large amounts of intravenous (IV) fluids will reduce the risk of developing a complication known as post-ERCP pancreatitis (PEP). Pancreatitis is inflammation of the pancreas, and it is the most frequent serious complication of ERCP. Typically, a small amount of IV fluids are given during this procedure (\~ 1 liter). We are testing whether using a larger amount of fluids (2 - 3 liters) will reduce the risk of PEP.

clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

Mick Meiselman, MD
Central Coast Gastroenterology
Study Director
clinicaltrials.gov ↗
Russell Brown, MD
Endeavor Health
Principal Investigator
clinicaltrials.gov ↗
Zachary Smith, MD
Medical College of Wisconsin
Study Director
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

6 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States

Northshore University Healthsystem
Evanston, Illinois, United States
Northshore University Healthsystem
Highland Park, Illinois, United States
Advocate Health Care
Skokie, Illinois, United States
Minnesota Gastroenterology
Plymouth, Minnesota, United States
University of Utah Health Care
Salt Lake City, Utah, United States
Medical College of Wisconsin
Milwaukee, Wisconsin, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 31 Jan 2014
Primary completion: 31 Jan 2016
Completion: 31 Jan 2016
Last update posted: 6 Sept 2019
Registered enrollment: 26
Registry id: NCT02050048

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.